Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lung Neoplasms (pathology) And NotAutophagy (drug effects)

List of bibliographic references

Number of relevant bibliographic references: 31.
Ident.Authors (with country if any)Title
000C08 Laurel M. Schunselaar [Pays-Bas] ; Kim Monkhorst [Pays-Bas] ; Vincent Van Der Noort [Pays-Bas] ; Ruud Wijdeven [Pays-Bas] ; Dennis Peters [Pays-Bas] ; Wilbert Zwart [Pays-Bas] ; Jacques Neefjes [Pays-Bas] ; Paul Baas [Pays-Bas]Trophoblast Glycoprotein is Associated With a Favorable Outcome for Mesothelioma and a Target for Antibody Drug Conjugates.
000C12 Tianyu Han [République populaire de Chine] ; Meng Guo [République populaire de Chine] ; Mingxi Gan [République populaire de Chine] ; Bentong Yu [République populaire de Chine] ; Xiaoli Tian [République populaire de Chine] ; Jian-Bin Wang [République populaire de Chine]TRIM59 regulates autophagy through modulating both the transcription and the ubiquitination of BECN1.
000C24 Michael J. Morgan [États-Unis] ; Brent E. Fitzwalter [États-Unis] ; Charles R. Owens [États-Unis] ; Rani K. Powers [États-Unis] ; Joseph L. Sottnik [États-Unis] ; Graciela Gamez [États-Unis] ; James C. Costello [États-Unis] ; Dan Theodorescu [États-Unis] ; Andrew Thorburn [États-Unis]Metastatic cells are preferentially vulnerable to lysosomal inhibition.
000C32 Yong Li [République populaire de Chine] ; Fengjun Cao [République populaire de Chine] ; Mingxing Li [République populaire de Chine] ; Pindong Li [République populaire de Chine] ; Yuandong Yu [République populaire de Chine] ; Longchao Xiang [République populaire de Chine] ; Tao Xu [République populaire de Chine] ; Jinhua Lei [République populaire de Chine] ; Yun Yan Tai [République populaire de Chine] ; Jianyong Zhu [République populaire de Chine] ; Bingbing Yang [République populaire de Chine] ; Yingpin Jiang [République populaire de Chine] ; Xiufang Zhang [République populaire de Chine] ; Long Duo [République populaire de Chine] ; Ping Chen [République populaire de Chine] ; Xiongjie Yu [République populaire de Chine]Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages.
000C38 Dana Wai Yi Tsui [Royaume-Uni] ; Muhammed Murtaza [Royaume-Uni] ; Alvin Seng Cheong Wong [Singapour] ; Oscar M. Rueda [Royaume-Uni] ; Christopher G. Smith [Royaume-Uni] ; Dineika Chandrananda [Royaume-Uni] ; Ross A. Soo [Singapour] ; Hong Liang Lim [Singapour] ; Boon Cher Goh [Singapour] ; Carlos Caldas [Royaume-Uni] ; Tim Forshew [Royaume-Uni] ; Davina Gale [Royaume-Uni] ; Wei Liu [Royaume-Uni] ; James Morris [Royaume-Uni] ; Francesco Marass [Royaume-Uni] ; Tim Eisen [Royaume-Uni] ; Tan Min Chin [Singapour] ; Nitzan Rosenfeld [Singapour]Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer.
000C41 Jingwen Xu [République populaire de Chine] ; Nipa H. Patel [États-Unis] ; Tareq Saleh [États-Unis] ; Emmanuel K. Cudjoe [États-Unis] ; Moureq Alotaibi ; Yingliang Wu [République populaire de Chine] ; Santiago Lima [États-Unis] ; Adam M. Hawkridge [États-Unis] ; David A. Gewirtz [États-Unis]Differential Radiation Sensitivity in p53 Wild-Type and p53-Deficient Tumor Cells Associated with Senescence but not Apoptosis or (Nonprotective) Autophagy.
000C44 Tingting Lv [République populaire de Chine] ; Ziying Li [République populaire de Chine] ; Liang Xu [République populaire de Chine] ; Yingying Zhang [République populaire de Chine] ; Haijun Chen [République populaire de Chine] ; Yu Gao [République populaire de Chine]Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer.
000D03 Xiao-Ming Jiang [République populaire de Chine] ; Yu-Lian Xu [République populaire de Chine] ; Mu-Yang Huang [République populaire de Chine] ; Le-Le Zhang [République populaire de Chine] ; Min-Xia Su [République populaire de Chine] ; Xiuping Chen [République populaire de Chine] ; Jin-Jian Lu [République populaire de Chine]Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR-mutated non-small cell lung cancer cells.
000D10 Bernhard Englinger [Autriche] ; Sebastian Kallus [Autriche] ; Julia Senkiv [Autriche] ; Daniela Heilos [Autriche] ; Lisa Gabler [Autriche] ; Sushilla Van Schoonhoven [Autriche] ; Alessio Terenzi [Autriche] ; Patrick Moser [Autriche] ; Christine Pirker [Autriche] ; Gerald Timelthaler [Autriche] ; Walter J Ger [Autriche] ; Christian R. Kowol [Autriche] ; Petra Heffeter [Autriche] ; Michael Grusch [Autriche] ; Walter Berger [Autriche]Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer.
000D17 Guorong Zhang ; Zhiqiang Liu ; Yan Chen ; Yihang ZhangHigh Serum HDGF Levels Are Predictive of Bone Metastasis and Unfavorable Prognosis in Non-Small Cell Lung Cancer.
000D49 Wen Cai Zhang [Singapour] ; Tan Min Chin [Singapour] ; Henry Yang [Singapour] ; Min En Nga [Singapour] ; Declan Patrick Lunny [Singapour] ; Edwin Kok Hao Lim [Singapour] ; Li Li Sun [Singapour] ; Yin Huei Pang [Singapour] ; Yi Ning Leow [Singapour] ; Shanneen Rossellini Y. Malusay [Singapour] ; Priscilla Xin Hui Lim [Singapour] ; Jeravan Zili Lee [Singapour] ; Benedict Jian Wei Tan [Singapour] ; Ng Shyh-Chang [Singapour] ; Elaine Hsuen Lim [Singapour] ; Wan Teck Lim [Singapour] ; Daniel Shao Weng Tan [Singapour] ; Eng Huat Tan [Singapour] ; Bee Choo Tai [Singapour] ; Ross Andrew Soo [Singapour] ; Wai Leong Tam [Singapour] ; Bing Lim [Singapour]Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression.
000D63 Yan Zhou [États-Unis] ; Yuan Li [États-Unis] ; Hong-Min Ni [États-Unis] ; Wen-Xing Ding [États-Unis] ; Hua Zhong [République populaire de Chine]Nrf2 but not autophagy inhibition is associated with the survival of wild-type epidermal growth factor receptor non-small cell lung cancer cells.
000E95 Akira Ikari [Japon] ; Saeko Taga [Japon] ; Ryo Watanabe [Japon] ; Tomonari Sato [Japon] ; Shun Shimobaba [Japon] ; Hiroyuki Sonoki [Japon] ; Satoshi Endo [Japon] ; Toshiyuki Matsunaga [Japon] ; Hideki Sakai [Japon] ; Masahiko Yamaguchi [Japon] ; Yasuhiro Yamazaki [Japon] ; Junko Sugatani [Japon]Clathrin-dependent endocytosis of claudin-2 by DFYSP peptide causes lysosomal damage in lung adenocarcinoma A549 cells.
001007 Haijun Yu [République populaire de Chine] ; Zhiai Xu ; Xianzhi Chen ; Leilei Xu ; Qi Yin ; Zhiwen Zhang ; Yaping LiReversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel.
001011 Simone Ragusa [Suisse] ; Jianpin Cheng [Suisse] ; Konstantin I. Ivanov [Suisse] ; Nadine Zangger [Suisse] ; Fatih Ceteci [Royaume-Uni] ; Jeremiah Bernier-Latmani [Suisse] ; Stavros Milatos [Suisse] ; Jean-Marc Joseph [Suisse] ; Stephane Tercier [Suisse] ; Hanifa Bouzourene [Suisse] ; Fredrik T. Bosman [Suisse] ; Igor Letovanec [Suisse] ; Giancarlo Marra [Suisse] ; Michel Gonzalez [Suisse] ; Patrizia Cammareri [Royaume-Uni] ; Owen J. Sansom [Royaume-Uni] ; Mauro Delorenzi [Suisse] ; Tatiana V. Petrova [Suisse]PROX1 promotes metabolic adaptation and fuels outgrowth of Wnt(high) metastatic colon cancer cells.
001025 Yan-Mei Zou [République populaire de Chine] ; Guang-Yuan Hu [République populaire de Chine] ; Xue-Qi Zhao [République populaire de Chine] ; Tao Lu [République populaire de Chine] ; Feng Zhu [République populaire de Chine] ; Shi-Ying Yu [République populaire de Chine] ; Hua Xiong [République populaire de Chine]Hypoxia-induced autophagy contributes to radioresistance via c-Jun-mediated Beclin1 expression in lung cancer cells.
001030 Mahmoud Toulany [Allemagne] ; Julia Mihatsch [Allemagne] ; Marina Holler [Allemagne] ; Hassan Chaachouay [Suisse] ; H Peter Rodemann [Allemagne]Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
001117 Rebekah L. Zinn [États-Unis] ; Eric E. Gardner ; Irina Dobromilskaya ; Sara Murphy ; Luigi Marchionni ; Christine L. Hann ; Charles M. RudinCombination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer.
001119 Stefanie Enzenmüller [Allemagne] ; Patrick Gonzalez ; Klaus-Michael Debatin ; Simone FuldaChloroquine overcomes resistance of lung carcinoma cells to the dual PI3K/mTOR inhibitor PI103 by lysosome-mediated apoptosis.
001122 Seung-Keun Hong [États-Unis] ; Jin-Hwan Kim ; Dmytro Starenki ; Jong-In ParkAutophagy sensitivity of neuroendocrine lung tumor cells.
001310 Sarah B. Goldberg [États-Unis] ; Jeffrey G. Supko ; Joel W. Neal ; Alona Muzikansky ; Subba Digumarthy ; Panos Fidias ; Jennifer S. Temel ; Rebecca S. Heist ; Alice T. Shaw ; Patricia O. Mccarthy ; Thomas J. Lynch ; Sreenath Sharma ; Jeffrey E. Settleman ; Lecia V. SequistA phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancer.
001476 Muhammad Zaeem Noman [France] ; Bassam Janji ; Bozena Kaminska ; Kris Van Moer ; Sandrine Pierson ; Piotr Przanowski ; Stéphanie Buart ; Guy Berchem ; Pedro Romero ; Fathia Mami-Chouaib ; Salem ChouaibBlocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression.
001929 Tao Ren [République populaire de Chine] ; Ying-Yun Cai ; Yong-Jie Liang ; Mei-Ling Jin ; Zhong-Liang Guo ; Meng-Fei Tao ; Xiang He[Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
001A57 Tao Ren [République populaire de Chine] ; Zhen-Ke Wen ; Zhong-Min Liu ; Yong-Jie Liang ; Zhong-Liang Guo ; Lin XuFunctional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis.
001C14 Chuandong Fan [République populaire de Chine] ; Weiwei Wang ; Baoxiang Zhao ; Shangli Zhang ; Junying MiaoChloroquine inhibits cell growth and induces cell death in A549 lung cancer cells.
001F14 H. Hashida [Japon] ; M. Miyamoto ; Y. Cho ; Y. Hida ; K. Kato ; T. Kurokawa ; S. Okushiba ; S. Kondo ; H. Dosaka-Akita ; H. KatohFusion of HIV-1 Tat protein transduction domain to poly-lysine as a new DNA delivery tool.
002432 M. Austin Taylor [États-Unis] ; M. Bennett ; V. Kumar ; J D SchatzleFunctional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
002852 S. Brenner [Israël] ; H. Golan ; A. Gat ; A. Bialy-GolanParaneoplastic subacute cutaneous lupus erythematosus: report of a case associated with cancer of the lung.
003A29 C. E. Orfanos [Allemagne] ; U. Runne [Allemagne]Tumor‐ and Drug‐Induced Cutaneous Neuro‐Phospholipidosis
003A49 N H Pazmi O ; J M YuhasChloroquine: nonselective inhibition of recovery from radiation injury in tumors and normal tissues.
003B79 I. Kimura ; Y. Moritani ; T. Onoshi ; H. Takata ; I. Kunimasa[Treatment of lung cancer (especially small-sized) with Bleomycin--significance of CPBP therapy].
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021